A Phase 3, Open-label, Randomized Study to Compare the Efficacy and Safety of Luspatercept (ACE-536) versus Epoetin Alfa for the Treatment of Anemia due to IPSS-R Very Low, Low or Intermediate Risk Myelodysplastic Syndromes (MDS) in ESA Naive Subjects who require Red Blood Cell Transfusions.

  • Tiong, Ing Soo (Primary Chief Investigator (PCI))
  • Kennedy, Nola (Chief Investigator (CI))

Project: Research

Project Details

Effective start/end date15/07/1931/12/24


  • Malignant Haematology
  • Anaemia
  • Blood transfusions
  • Clinical trial